Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)

ClinicalTrials.gov ID: NCT03608397

Public ClinicalTrials.gov record NCT03608397. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 10:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial to Evaluate the Efficacy and Safety of a Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, placebo-controlled, parallel group, multi-center trial of two doses of daxibotulinumtoxinA (DAXI) for injection (high-dose; low-dose in adult subjects with isolated (primary) cervical dystonia (CD).

Study identification

NCT ID
NCT03608397
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Revance Therapeutics, Inc.
Industry
Enrollment
301 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 20, 2018 (Actual)
Primary completion
Dec 3, 2019 (Actual)
Completion
Jun 16, 2020 (Actual)
Last update posted
Dec 5, 2022

2018 – 2020

United States locations

U.S. sites
44
U.S. states
19
U.S. cities
41
Facility City State ZIP Site status
HOPE Research Institute Phoenix Arizona 85018 —
Movement Disorders Center of Arizona Scottsdale Arizona 85258-4581 —
The Parkinsons and Movement Disorder Institute Fountain Valley California 92708 —
University of California, Irvine Irvine California 92697 —
Loma Linda University Loma Linda California 92354 —
USC Keck School of Medicine Los Angeles California 90033 —
Care Access Research Pasadena California 91101 —
Sutter Institute for Medical Research Sacramento California 95816 —
Rocky Mountain Movement Disorders Center Englewood Colorado 80113 —
Associated Neurologist, P.C. Danbury Connecticut 06810 —
New England Institute for Clinical Research Stamford Connecticut 06905 —
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486 —
Design Neuroscience Center Doral Florida 33172 —
University of Florida Center for Movement Disorders and Neurorestoration Gainesville Florida 32607 —
Infinity Clinical Research Hollywood Florida 33024 —
University of Florida Health Science Center Jacksonville Jacksonville Florida 32209 —
University of Miami Miami Florida 33136 —
Suncoast Neuroscience Associates St. Petersburg Florida 33713-8844 —
USF Parkinson's Disease and Movement Disorders Center Tampa Florida 33613 —
Emory University Atlanta Georgia 30329 —
Rush University Medical Center Chicago Illinois 60612 —
Kansas Institute of Reseach Overland Park Kansas 66211-1358 —
Michigan State University East Lansing Michigan 48824 —
QUEST Research Institute Farmington Michigan 48334 —
Henry Ford West Bloomfield Hospital West Bloomfield Michigan 48322 —
St Louis University St Louis Missouri 63105 —
Washington University St Louis Missouri 63110 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
Mount Sinai Movement Disorders Center New York New York 10029 —
University of Rochester Rochester New York 14618 —
Duke University Durham North Carolina 27710 —
Wake Forest Health Sciences Winston-Salem North Carolina 27157 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
University of Pennsylvania, Department of Neurology Philadelphia Pennsylvania 19107 —
Medical University of South Carolina Charleston South Carolina 29425 —
Coastal Neurology Port Royal South Carolina 29935 —
Wesley Neurology Clinic Cordova Tennessee 38018 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Texas Neurology. P.A. Dallas Texas 37232 —
Baylor College of Medicine Houston Texas 77030 —
Houston Methodist Neurological Institute Houston Texas 77030 —
Central Texas Neurology Consultants Round Rock Texas 78681 —
University of Vermont Medical Center Burlington Vermont 05401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03608397, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 5, 2022 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03608397 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →